Development of adapted RECIST criteria to assess response in lymphoma and their comparison to the International Workshop Criteria

References

• Therasse P, Arbuck S G, Eisenhauer E A, Wanders J, Kaplan R S, Rubinstein L, et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 2000; 92: 205–216
   PubMed Web of Science ®Google Scholar
• Eisenhauer E A, Bonetti M, Gelber R D. Principles of clinical trials. Textbook of Medical Oncology, 2nd ed, F Cavalli, H H Hansen, S B Kaye. Martin Dunitz, London 2000; 99–136, Ch. 3
   Google Scholar
• James K, Eisenhauer E, Christian M, Terenziani M, Vena D, Muldal A, Therasse P. Measuring response in solid tumors: unidimensional versus bidimensional measurement. J Natl Cancer Inst 1999; 91: 523–528
   PubMed Web of Science ®Google Scholar
• WHO handbook for reporting results of cancer treatment. WHO, GenevaSwitzerland 1979, World Health Organization Offset Publication No. 48
   Google Scholar
• Erasmus J J, Gladish G W, Broemeling B S, Truong M T, Herbst R S, Munden R F. Interobserver and intraobserver variability in measurement of non-small-cell carcinoma lung lesions: implications for assessment of tumor response. J Clin Oncol 2003; 21: 2574–2582
   PubMed Web of Science ®Google Scholar
• Cheson B, Horning S J, Coiffier B, Shipp M A, Fisher R I, Connors J M, et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. J Clin Oncol 1999; 17: 1244–1253
   PubMed Web of Science ®Google Scholar
• Cheson B D, Pfistner B, Juweid M E, Horning S J, Coiffier B, Gascoyne R D, Fisher R I, et al. International Harmonization Project. Recommendations for revised response criteria for malignant lymphoma. J Clin Oncol 2006; 24: 7507, ASCO Annual Meeting Proceedings Part I. Vol 24, No. 18S (June 20 Supplement), 2006; Abstract No. 7507
   Google Scholar
• Cheson B D, Pfistner B, Juweid M E, Specht L, Rosen S T, Gascoyne R, et al. Revised response criteria for malignant lymphomas. From the members of the International Harmonization Project (IHP) of the Competence Network Malignant Lymphoma. Blood 2005; 106((Suppl.)), Abstract No. 18
   Google Scholar
• Dorfman R E, Alpern M B, Gross B H, Sandler M A. Upper abdominal lymph nodes: criteria for normal size determined with CT. Radiology 1991; 180: 319–322
   PubMed Web of Science ®Google Scholar
• Glazer G M, Gross B H, Quint L E, Francis I R, Bookstein F I, Orringer M B, et al. Normal mediastinal lymph nodes: number and size according to American Thoracic Society mapping. Am J Roentgenol 1985; 144: 261–265
   PubMed Web of Science ®Google Scholar
• Steinkamp H J, Hosten N, Richter C, Schedel H, Felix R. Enlarged cervical lymph nodes at helical CT. Radiology 1994; 191: 795–798
   PubMed Web of Science ®Google Scholar
• Strijk S P, Boetes C, Bogman M J, del Pauw B E, Wobbes T. The spleen in non-Hodgkin lymphoma: diagnostic value of computed tomography. Acta Radiol 1987; 28: 139–144
   PubMed Web of Science ®Google Scholar
• Kouroukis C T, Belch A, Crump M, Eisenhauer E, Gascoyne R D, Myers R, et al. Flavopiridol in untreated or relapsed mantle-cell lymphoma: results of a phase II study of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 2003; 21: 1740–1745
   PubMed Web of Science ®Google Scholar
• Baetz T, Belch A, Couban S, Imrie K, Yau J, Myers R, et al. Gemcitabine, dexamethasone and cisplatin is an active and non-toxic chemotherapy regimen in relapsed or refractory Hodgkin's disease: a phase II study by the National Cancer Institute of Canada Clinical Trials Group. Ann Oncol 2003; 14: 1762–1767
   PubMed Web of Science ®Google Scholar
• Crump M, Baetz T, Couban S, Belch A, Marcellus D, Howson-Jan K, et al. Gemcitabine, dexamethasone, and cisplatin in patients with recurrent or refractory aggressive histology B-cell non-Hodgkin lymphoma: a phase II study by the National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG). Cancer 2004; 101: 1835–1842
   PubMed Web of Science ®Google Scholar
• Assouline S, Belch A, Sehn L, Kouroukis C T, Gascoyne R, Meyer R, Eisenhauer E. A phase II trial of bortezomib in patients with mantle cell lymphoma. Blood 2003; 102, Abstract No. 3358
   Google Scholar
• McKinnon A. A spreadsheet for the calculation of comprehensive statistics for the assessment of diagnostic tests and inter-rater agreement. Computers Biol Med 2000; 30: 127–134
   PubMed Web of Science ®Google Scholar
• Czuczman M S, Koryzna A, Mohr A, Stewart C, Donahue K, Blumenson L, et al. Rituximab in combination with fludarabine chemotherapy in low-grade or follicular lymphoma. J Clin Oncol 2005; 23: 694–704
   PubMed Web of Science ®Google Scholar
• Czuczman M S, Weaver R, Alkuzweny B, Berlfein J, Grillo-Lopez A J. Prolonged clinical and molecular remission in patients with low-grade or follicular non-Hodgkin's lymphoma treated with rituximab plus CHOP chemotherapy: 9-year follow-up. J Clin Oncol 2004; 22: 4711–4716
   PubMed Web of Science ®Google Scholar
• Darby A, Gribben J G. Follicular lymphoma: quantitation of minimal residual disease by PCR of the t(14;18) translocation. Methods Mol Med 2005; 115: 315–331
   PubMedGoogle Scholar
• Howard O M, Gribben J G, Neuberg D S, Grossbard M, Poor C, Janicek M J, Shipp M A. Rituximab and CHOP induction therapy for newly diagnosed mantle-cell lymphoma: molecular complete responses are not predictive of progression-free survival. J Clin Oncol 2002; 20: 1288–1294
   PubMed Web of Science ®Google Scholar
• Pott C, Schrader C, Gesk S, Harder L, Tiemann M, Raff T, et al. Quantitative assessment of molecular remission following high-dose therapy with autologous stem cell transplantation predicts long term remission in mantle cell lymphoma. Blood 2006; 107: 2271–2278
   PubMed Web of Science ®Google Scholar
• Juweid M E, Wiseman G A, Vose J M, Ritchie J M, Menda Y, Wooldridge J E, et al. Response assessment of aggressive non-Hodgkin's lymphoma by integrated international workshop criteria and fluorine-18-fluorodeoxyglucose positron emission tomography. J Clin Oncol 2005; 23: 1–10
   PubMed Web of Science ®Google Scholar